Literature DB >> 28066923

Reply to Ruan X et al: "A comment on pattern of opioid use in sickle cell disease".

Jin Han1,2,3, Santosh L Saraf2, Roberto F Machado4, Victor R Gordeuk2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28066923      PMCID： PMC5547438          DOI： 10.1002/ajh.24646

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

1.  Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home.

Authors:  Samir K Ballas; Robert L Bauserman; William F McCarthy; Oswaldo L Castro; Wally R Smith; Myron A Waclawiw
Journal:  J Pain Symptom Manage       Date:  2010-12       Impact factor: 3.612

2.  Patterns of opioid use in sickle cell disease.

Authors:  Jin Han; Santosh L Saraf; Xu Zhang; Michel Gowhari; Robert E Molokie; Joharah Hassan; Chaher Alhandalous; Shivi Jain; Jewel Younge; Taimur Abbasi; Roberto F Machado; Victor R Gordeuk
Journal:  Am J Hematol       Date:  2016-08-08       Impact factor: 10.047

Review 3.  Sickle cell pain: a critical reappraisal.

Authors:  Samir K Ballas; Kalpna Gupta; Patricia Adams-Graves
Journal:  Blood       Date:  2012-08-24       Impact factor: 22.113
  3 in total
  1 in total

1.  Characterization of opioid use in sickle cell disease.

Authors:  Jin Han; Jifang Zhou; Santosh L Saraf; Victor R Gordeuk; Gregory S Calip
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-08-16       Impact factor: 2.890
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.